Axcella Health Inc. Stock News

Axcella Health Inc (AXLA) shares closed today at 1.6% above its 52 week low of $1.85, giving the company a market cap of $73M. The stock is currently down 10.0% year-to-date, down 63.9% over the past 12 months, and down 86.4% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 0.7%. Trading Activity Trading volume this week was 57.5% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 2436.4% The company's stock price performance over the past 12 months lags the peer average by 647.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Cigna (CI) is well-poised for growth, attributable to solid segmental contributions, the continuous launch of affordable MA plans, a strong partner network and sufficient cash reserves.

Axcella Health Inc (AXLA) shares closed 1.5% lower than its previous 52 week low, giving the company a market cap of $79M. The stock is currently down 2.9% year-to-date, down 61.7% over the past 12 months, and down 85.3% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 3.0% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 1001.6% The company's stock price performance over the past 12 months lags the peer average by 731.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Axcella Health Inc (AXLA) shares closed today at 1.5% above its 52 week low of $2.00, giving the company a market cap of $79M. The stock is currently down 2.9% year-to-date, down 61.7% over the past 12 months, and down 85.3% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 53.4% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 1001.6% The company's stock price performance over the past 12 months lags the peer average by 731.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Axcella Health Inc (AXLA) shares closed 1.5% lower than its previous 52 week low, giving the company a market cap of $81M. The stock is currently flat year-to-date, down 59.7% over the past 12 months, and down 84.9% over the past five years. This week, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 1.7%. Trading Activity Trading volume this week was 53.4% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 4.7% lower than its 5-day moving average, 11.9% lower than its 20-day moving average, and 29.2% lower than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -100.0% The company's stock price performance over the past 12 months lags the peer average by 739.9% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Axcella Therapeutics (AXLA) is trading ~3.4% lower after the company laid out its upcoming clinical and operational milestones for this year.Notable events for 2022 include an

UnitedHealth Group (UNH) is well-poised for growth on the back of solid top-line growth, expansion of service offerings through UnitedHealthcare and Optum units, and adequate cash flows.

The heavy selling pressure might have exhausted for Axcella Health Inc. (AXLA) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street

The heavy selling pressure might have exhausted for Axcella Health Inc. (AXLA) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street

Axcella Health Inc (AXLA) shares closed 0.9% lower than its previous 52 week low, giving the company a market cap of $89M. The stock is currently down 55.9% year-to-date, down 57.8% over the past 12 months, and down 83.4% over the past five years. This week, the Dow Jones Industrial Average rose 3.9%, and the S&P 500 rose 4.9%. Trading Activity Trading volume this week was 156.9% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 88.0% The company's stock price performance over the past 12 months lags the peer average by 85.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Compass Therapeutics (OTC:CMPX) and Axcella Health (NASDAQ:AXLA) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, earnings, analyst recommendations, risk, profitability, valuation and institutional ownership. Analyst Recommendations This is a summary of recent recommendations and price targets for Compass Therapeutics []

Axcella Health (NASDAQ:AXLA) was upgraded by Zacks Investment Research from a hold rating to a buy rating in a research note issued to investors on Tuesday, Zacks.com reports. The brokerage currently has a $2.75 price objective on the stock. Zacks Investment Researchs price target would indicate a potential upside of 12.70% from the companys previous []

Zacks Investment Research cut shares of Axcella Health (NASDAQ:AXLA) from a buy rating to a hold rating in a report issued on Tuesday, Zacks.com reports. According to Zacks, Axcella Health Inc. is a biotechnology company. It is engaged in the research and development of novel multifactorial interventions to support health and address dysregulated metabolism. The []

State Street Corp decreased its position in shares of Axcella Health Inc. (NASDAQ:AXLA) by 68.5% during the 2nd quarter, HoldingsChannel reports. The fund owned 70,676 shares of the companys stock after selling 153,426 shares during the quarter. State Street Corps holdings in Axcella Health were worth $283,000 at the end of the most recent quarter. []